Emergent rises after naming former Bausch + Lomb top boss as CEO
** Shares of Emergent BioSolutions EBS.N rise 17.8% to
$1.79 in premarket trading
** Co says it has appointed Joseph Papa as its new CEO,
effective Feb. 21
** Papa most recently was CEO and Chairman at Bausch + Lomb
BLCO.TO BLCO.N
** Haywood Miller will step down from his role as interim
CEO
** Up to last close, stock down 90.7% in the last 12 months
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser